Up-regulation and coexpression of MIF and matrix metalloproteinases in human abdominal aortic aneurysms

Antioxidants and Redox Signaling

Volumn 7, Issue 9-10, 2005, Pages 1195-1202

  Verschuren, Lars ^a,b   Lindeman, Jan H N ^a,b   Van Hajo Bockel, J ^b   Abdul Hussien, Hazem ^b   Kooistra, Teake ^a   Kleemann, Robert ^a,b  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MACROPHAGE MIGRATION INHIBITION FACTOR; MATRIX METALLOPROTEINASE;

ABDOMINAL AORTA ANEURYSM; AORTA WALL; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; CELLULAR DISTRIBUTION; CYTOTOXICITY; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; UPREGULATION;

AORTA; AORTIC ANEURYSM, ABDOMINAL; BLOTTING, WESTERN; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 12; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MYOCYTES, SMOOTH MUSCLE; NUCLEIC ACIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; UP-REGULATION;

EID: 24144494552     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.1195     Document Type: Article

References (26)

1. [No authors listed] Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial Participants. Lancet 352: 1649-1655, 1998.
2. Allaire E, Forough R, Clowes M, Starcher B, and Clowes AW. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invest 102: 1413-1420, 1998.
3. Anidjar S, Dobrin PB, Eichorst M, Graham GP, and Chejfec G. Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysms. J Vasc Surg 16: 139-147, 1992.
4. Annabi B, Shedid D, Ghosn P, Kenigsberg RL, Desrosiers RR, Bojanowski MW, Beaulieu E, Nassif E, Moumdjian R, and Beliveau R. Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms. J Vasc Surg 35: 539-546, 2002.
5. Armstrong PJ, Johanning JM, Calton WC Jr, Delatore JR, Franklin DP, Han DC, Carey DJ, and Elmore JR. Differential gene expression in human abdominal aorta: aneurysmal versus occlusive disease. J Vasc Surg 35: 346-355, 2002.
6. Binder CJ, Chang MK, Shaw PX, Miller YI, Hartvigsen K, Dewan A, and Witztum JL. Innate and acquired immunity in atherogenesis. Nat Med 8: 1218-1226, 2002.
7. Brown DL, Hibbs MS, Kearney M, Loushin C, and Isner JM. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation 91: 2125-2131, 1995.
8. Burger-Kentischer A, Goebel H, Seiler R, Fraedrich G, Schaefer HE, Dimmeler S, Kleemann R, Bernhagen J, and Ihling C. Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation 105: 1561-1566, 2002.
9. Calandra T and Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3: 791-800, 2003.
10. Curci JA, Liao S, Huffman MD, Shapiro SD, and Thompson RW. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest 102: 1900-1910, 1998.
11. Delsing DJ, Offerman EH, van Duyvenvoorde W, van der Boom H, de Wit EC, Gijbels MJ, van der Laarse A, Jukema JW Havekes LM, and Princen HM. Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leidenmice. Circulation 103: 1778-1786, 2001.
12. Gervois P, Kleemann R, Pilon A, Percevault F, Koenig W, Staels B, and Kooistra T. Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate. J Biol Chem 279: 16154-16160, 2004.
13. Kato S, Yasukawa H, Fujii T, Yamaguchi M, Miyagi N, Okamoto K, Wada Y Miyamoto T, Morimatsu M, and Fox JC. Coordinate regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression in human vascular smooth muscle cells. Connect Tissue Res 41: 143-153, 2000.
14. Libby P, Ridker PM, and Maseri A. Inflammation and atherosclerosis. Circulation 105: 1135-1143, 2002.
15. Lue H, Kleemann R, Calandra T, Roger T, and Bernhagen J. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 4: 449-460, 2002.
16. Mocellin S, Provenzano M, Rossi CR, Pilati P, Nitti D, and Lise M. Use of quantitative real-time PCR to determine immune cell density and cytokine gene profile in the tumor microenvironment. J Immunol Methods 280: 1-11, 2003.
17. Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, and Nishihira J. Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem 275: 444-450, 2000.
18. Onodera S, Nishihira J, Iwabuchi K, Koyama Y, Yoshida K, Tanaka S, and Minami A. Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways. J Biol Chem 277: 7865-7874, 2002.
19. Pan JH, Lindholt JS, Sukhova GK, Baugh JA, Henneberg EW, Bucala R, Donnelly SC, Libby P, Metz C, and Shi GP. Macrophage migration inhibitory factor is associated with aneurysmal expansion. J Vasc Surg 37: 628-635, 2003.
20. Pearce WH and Koch AE. Cellular components and features of immune response in abdominal aortic aneurysms. Ann N Y Acad Sci 800: 175-185, 1996.
21. Schober A, Bernhagen J, Thiele M, Zeiffer U, Knarren S, Roller M, Bucala R, and Weber C. Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice. Circulation 109: 380-385, 2004.
22. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 8: 1211-1217, 2002.
23. Tamarina NA, McMillan WD, Shively VP, and Pearce WH. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery 122: 264-271, 1997.
24. Thompson RW. Basic science of abdominal aortic aneurysms: emerging therapeutic strategies for an unresolved clinical problem. Curr Opin Cardiol 11: 504-518, 1996.
25. Trogan E, Choudhury RP, Dansky HM, Rong JX, Breslow JL, and Fisher EA. Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A 99: 2234-2239, 2002.
26. White JV and Mazzacco SL. Formation and growth of aortic aneurysms induced by adventitial elastolysis. Ann N Y Acad Sci 800: 97-120, 1996.